Clinical Trial Update: Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

A randomized phase II trial evaluating liposomal doxorubicin (Doxil) with or without dexamethasone in metastatic hormone-refractory prostate cancer was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Doxil (liposomal doxorubicin)

Snippet

Sponsor: University of Kentucky | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED